Biosimilars and Future Biotherapeutics

Advancements in Biosimilar Development Technologies

Advancements in Biosimilar Development Technologies the latest scientific and technical innovations that are revolutionizing the way biosimilars are developed, manufactured, and brought to market. As the global demand for affordable biologic therapies grows, the need for efficient and precise biosimilar development strategies has become more critical than ever. the growing role of analytical characterization tools, such as high-resolution mass spectrometry, capillary electrophoresis, and advanced chromatography techniques, in demonstrating structural and functional similarity to reference biologics. These technologies are critical for establishing biosimilarity at the molecular level, which is the cornerstone of regulatory approval. In addition, attendees will learn how process analytical technology (PAT) and quality by design (QbD) principles are being integrated into biosimilar development pipelines to ensure greater process control and regulatory compliance. The session will also highlight advancements in in-silico modeling, bioinformatics, and machine learning applications that are streamlining development timelines and optimizing manufacturing workflows.